These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
624 related articles for article (PubMed ID: 34428777)
1. Emergence and expansion of SARS-CoV-2 B.1.526 after identification in New York. Annavajhala MK; Mohri H; Wang P; Nair M; Zucker JE; Sheng Z; Gomez-Simmonds A; Kelley AL; Tagliavia M; Huang Y; Bedford T; Ho DD; Uhlemann AC Nature; 2021 Sep; 597(7878):703-708. PubMed ID: 34428777 [TBL] [Abstract][Full Text] [Related]
2. Emergence and Expansion of the SARS-CoV-2 Variant B.1.526 Identified in New York. Annavajhala MK; Mohri H; Wang P; Nair M; Zucker JE; Sheng Z; Gomez-Simmonds A; Kelley AL; Tagliavia M; Huang Y; Bedford T; Ho DD; Uhlemann AC medRxiv; 2021 Aug; ():. PubMed ID: 33655278 [TBL] [Abstract][Full Text] [Related]
3. Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7. Wang P; Nair MS; Liu L; Iketani S; Luo Y; Guo Y; Wang M; Yu J; Zhang B; Kwong PD; Graham BS; Mascola JR; Chang JY; Yin MT; Sobieszczyk M; Kyratsous CA; Shapiro L; Sheng Z; Huang Y; Ho DD Nature; 2021 May; 593(7857):130-135. PubMed ID: 33684923 [TBL] [Abstract][Full Text] [Related]
4. B.1.526 SARS-CoV-2 Variants Identified in New York City are Neutralized by Vaccine-Elicited and Therapeutic Monoclonal Antibodies. Zhou H; Dcosta BM; Samanovic MI; Mulligan MJ; Landau NR; Tada T mBio; 2021 Aug; 12(4):e0138621. PubMed ID: 34311587 [TBL] [Abstract][Full Text] [Related]
5. The Impact on Infectivity and Neutralization Efficiency of SARS-CoV-2 Lineage B.1.351 Pseudovirus. Kim YJ; Jang US; Soh SM; Lee JY; Lee HR Viruses; 2021 Apr; 13(4):. PubMed ID: 33917138 [TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern. Kovacech B; Fialova L; Filipcik P; Skrabana R; Zilkova M; Paulenka-Ivanovova N; Kovac A; Palova D; Rolkova GP; Tomkova K; Csokova NT; Markova K; Skrabanova M; Sinska K; Basheer N; Majerova P; Hanes J; Parrak V; Prcina M; Cehlar O; Cente M; Piestansky J; Fresser M; Novak M; Slavikova M; Borsova K; Cabanova V; Brejova B; Vinař T; Nosek J; Klempa B; Eyer L; Hönig V; Palus M; Ruzek D; Vyhlidalova T; Strakova P; Mrazkova B; Zudova D; Koubkova G; Novosadova V; Prochazka J; Sedlacek R; Zilka N; Kontsekova E EBioMedicine; 2022 Feb; 76():103818. PubMed ID: 35078012 [TBL] [Abstract][Full Text] [Related]
15. A Bifluorescent-Based Assay for the Identification of Neutralizing Antibodies against SARS-CoV-2 Variants of Concern Chiem K; Morales Vasquez D; Silvas JA; Park JG; Piepenbrink MS; Sourimant J; Lin MJ; Greninger AL; Plemper RK; Torrelles JB; Walter MR; de la Torre JC; Kobie JK; Ye C; Martinez-Sobrido L J Virol; 2021 Oct; 95(22):e0112621. PubMed ID: 34495697 [TBL] [Abstract][Full Text] [Related]
16. Detection of a SARS-CoV-2 variant of concern in South Africa. Tegally H; Wilkinson E; Giovanetti M; Iranzadeh A; Fonseca V; Giandhari J; Doolabh D; Pillay S; San EJ; Msomi N; Mlisana K; von Gottberg A; Walaza S; Allam M; Ismail A; Mohale T; Glass AJ; Engelbrecht S; Van Zyl G; Preiser W; Petruccione F; Sigal A; Hardie D; Marais G; Hsiao NY; Korsman S; Davies MA; Tyers L; Mudau I; York D; Maslo C; Goedhals D; Abrahams S; Laguda-Akingba O; Alisoltani-Dehkordi A; Godzik A; Wibmer CK; Sewell BT; Lourenço J; Alcantara LCJ; Kosakovsky Pond SL; Weaver S; Martin D; Lessells RJ; Bhiman JN; Williamson C; de Oliveira T Nature; 2021 Apr; 592(7854):438-443. PubMed ID: 33690265 [TBL] [Abstract][Full Text] [Related]
17. Antigenicity of the Mu (B.1.621) and A.2.5 SARS-CoV-2 Spikes. Chatterjee D; Tauzin A; Laumaea A; Gong SY; Bo Y; Guilbault A; Goyette G; Bourassa C; Gendron-Lepage G; Medjahed H; Richard J; Moreira S; Côté M; Finzi A Viruses; 2022 Jan; 14(1):. PubMed ID: 35062348 [TBL] [Abstract][Full Text] [Related]
18. Impact of the N501Y substitution of SARS-CoV-2 Spike on neutralizing monoclonal antibodies targeting diverse epitopes. Cheng L; Song S; Zhou B; Ge X; Yu J; Zhang M; Ju B; Zhang Z Virol J; 2021 Apr; 18(1):87. PubMed ID: 33910569 [TBL] [Abstract][Full Text] [Related]
19. Sensitivity of two SARS-CoV-2 variants with spike protein mutations to neutralising antibodies. Müller K; Girl P; Giebl A; Gruetzner S; Antwerpen M; Khatamzas E; Wölfel R; von Buttlar H Virus Genes; 2021 Dec; 57(6):502-509. PubMed ID: 34608598 [TBL] [Abstract][Full Text] [Related]